BF, I think if we could streamline the awareness m
Post# of 148175
(Total Views: 478)
Posted On: 08/13/2020 12:30:36 PM
BF, I think if we could streamline the awareness message to our contacts that would be very very helpful.Consistent message to all. A lot on the board have made "mock PR's" that they think would work. It could be a "board" effort that included study results but concise and impactful. Any thoughts?
Headline " CytoDyn a small biotech, submits to FDA its' COVID 19 drug, Leronlimab, for EUA approval. Leronlimab, an Immune Modulator, is the FIRST DRUG in the MM category to show in Phase 2 study ( randomized double blind placebo controlled) significant results AT DAY 3- 90% of patients showed significant improvement in symptoms vs. Placebo arm at 70%. ****Or what ever is the most compelling. We could add links like the MOA and study.
What do you think? Board?
Headline " CytoDyn a small biotech, submits to FDA its' COVID 19 drug, Leronlimab, for EUA approval. Leronlimab, an Immune Modulator, is the FIRST DRUG in the MM category to show in Phase 2 study ( randomized double blind placebo controlled) significant results AT DAY 3- 90% of patients showed significant improvement in symptoms vs. Placebo arm at 70%. ****Or what ever is the most compelling. We could add links like the MOA and study.
What do you think? Board?
(4)
(1)CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼